Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Baxter
Dow
Accenture
Covington
Federal Trade Commission
Boehringer Ingelheim
McKesson

Generated: June 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin detemir recombinant

« Back to Dashboard

insulin detemir recombinant

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA Novo Nordisk N 0169-3687-12
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA Novo Nordisk N 0169-6438-10
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA Novo Nordisk N 0169-6438-98
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA A-S Medication Solutions N 50090-1276-0
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Healthtrust
Express Scripts
Moodys
Merck
Boehringer Ingelheim
Cerilliant
Covington
Harvard Business School